April is Esophageal Cancer Awareness Month

Esophageal cancer is one of the fastest and deadliest cancers in the United States, United Kingdom and other western countries. 

The Salgi Esophageal Cancer Research Foundation awarded two research grants! The first in 2015 and the second in 2018.  The research awarded in 2018, a breath test for esophageal cancer, is currently underway.  Both grants were given in honor of all the men and women affected by esophageal cancer. While these are tremendous accomplishments, esophageal cancer research is critically underfunded and medical researchers continuously inquire about funding.   

In addition, the COVID-19 pandemic has greatly impacted or delayed screenings, diagnosis and treatments for many individuals who may now be facing advanced prognosis.  

Now more than ever, your support is critically needed to enable this charity to fulfill our mission.

Learn the Facts: 

-Esophageal cancer increased over 700% in the past four decades. 

-Esophageal cancer is one of the fastest growing cancers in the United States and western world. 

-Esophageal cancer has an overall 5 year survival rate of only 19.9%. 

-There are no routine or standard screenings. 

-Symptoms often arise late, once the cancer has spread. 

-Stage IV has a survival rate of only 5.2%. 

-Esophageal cancer research is critically underfunded. 

-In 2016, an estimated $1.6 billion was spent on esophageal cancer care in the United States. 

-2022 estimates for esophageal cancer: 20,640 diagnoses & 16,410 deaths.

2022 Infographic

Save the infographic below and share it on social media to help raise awareness. Tag us in your posts. @SalgiFoundation

Donate Today!

Donate today to our ‘April is Esophageal Cancer Awareness Month’ Facebook fundraiser! Facebook makes it easy to donate and share the campaign. 100% of all donations go directly towards our mission. Click the button or link below.

https://www.facebook.com/donate/1174090410029167/

“Awareness, early detection, research…in hopes of a CURE!™”

Share this:

Comments are closed.

%d bloggers like this: